Arrowstreet Capital
BLU

Arrowstreet Capital’s BELLUS Health Inc. BLU Stock Holding History

Arrowstreet Capital’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-492,798
Closed -$1.51M – 2626
2020
Q4 		$1.51M Buy
492,798
+175,098
+55% +$474K ﹤0.01% 1702
2020
Q3 		$721K Buy
+317,700
New +$901K ﹤0.01% 1908

Other funds holding BLU

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Arrowstreet Capital's BLU Position: Q1 2021 in Review

Arrowstreet Capital sold out of BELLUS Health Inc. (BLU) in Q1 2021, closing a stake of 492,798 shares — an estimated $1.51M sold.

Arrowstreet Capital first reported a position in BLU in Q3 2020 and held it in 2 quarters. The position peaked at $1.51M in Q4 2020. 48 funds tracked by Wall St. Rank hold BLU as of Q1 2021.

  • Arrowstreet Capital reported no remaining BELLUS Health Inc. position as of Q1 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 492,798 BELLUS Health Inc. shares in Q1 2021, an estimated $1.51M.
  • Arrowstreet Capital first reported a position in BELLUS Health Inc. in Q3 2020 and held it in 2 quarters.
  • Arrowstreet Capital's BELLUS Health Inc. position peaked at $1.51M in Q4 2020.
  • 48 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.